Home › NDC Lookup › RxCUI directory › RxCUI 2640900

{4 (0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector) } Pack — RxCUI 2640900

RxNorm drug concept · Generic pack
RxCUI 2640900 Generic pack · GPCK ● Current RxNorm concept 12 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2640900
Official name{4 (0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asadalimumab-adbm Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count)
FDA products mapped12
Package NDCs mapped12
Reported Medicaid activity (SDUD)4,546 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Adalimumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It calms inflammation in conditions like rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis. Whi...
  • It goes under the skin of your thigh or abdomen. Rotate sites and avoid tender, bruised or red skin. You can let it warm up for 15 to 30 minutes first, with the cap on. If you miss...
  • Injection site redness, itching or pain is the most common. Colds, sinus infections, headache and rash are also common. These are usually mild.
  • Call right away for fever, chills, cough or any sign of infection, since serious infections can happen. Also call for signs of allergic reaction, new nerve or vision problems, unus...
📖 Read our full Adalimumab Injection guide →

🕸️ Concept Web — How {4 (0.8 ML adalimumab-adbm 50 MG/ML Auto-Injecto... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {4 (0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector) } Pack RxCUI 2640900

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Adalimumab 327361
    • Adalimumab-adbm 2103477
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cyltezo 2640885
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Adalimumab Auto-Injector 1655725
    • Adalimumab-adbm Auto-Injector 2647030
    • Adalimumab Injectable Product 1163691
    • Adalimumab-adbm Injectable Product 2663270
    • Adalimumab Auto-Injector [Cyltezo] 2640897
    • Adalimumab-adbm Auto-Injector [Cyltezo] 2656908
    • Cyltezo Injectable Product 2640887
    • Pack 746839
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector SCD · 2640895
  • Adalimumab-adbm 50 MG/ML SCDC · 2640882
  • Adalimumab Auto-Injector SCDF · 1655725
  • Adalimumab-adbm Auto-Injector SCDFP · 2647030
  • Adalimumab Injectable Product SCDG · 1163691
  • Adalimumab-adbm Injectable Product SCDGP · 2663270

Brand-Name Concepts

📦 FDA Products & Package NDCs

12 products · 12 package NDCs
12 package NDCs map to RxCUI 2640900 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00597-0370-82 2 KIT in 1 CARTON (0597-0370-82) / 1 KIT in 1 KIT * 1 SYRI... Cyltezo Boehringer Ingelheim Pharmaceuticals, Inc. 2023-07-01
00597-0375-97 2 KIT in 1 CARTON (0597-0375-97) / 1 KIT in 1 KIT * 1 SYRI... Cyltezo Boehringer Ingelheim Pharmaceuticals, Inc. 2023-07-01
00597-0400-89 2 KIT in 1 CARTON (0597-0400-89) / 1 KIT in 1 KIT * 1 SYRI... Cyltezo Boehringer Ingelheim Pharmaceuticals, Inc. 2023-07-01
00597-0405-80 2 KIT in 1 CARTON (0597-0405-80) / 1 KIT in 1 KIT * 1 SYRI... Cyltezo Boehringer Ingelheim Pharmaceuticals, Inc. 2023-07-01
00597-0485-20 2 KIT in 1 CARTON (0597-0485-20) / 1 KIT in 1 KIT * 1 SYRI... Cyltezo Boehringer Ingelheim Pharmaceuticals, Inc. 2024-04-30
00597-0495-50 2 KIT in 1 CARTON (0597-0495-50) / 1 KIT in 1 KIT * 1 SYRI... Cyltezo Boehringer Ingelheim Pharmaceuticals, Inc. 2024-04-30
00597-0545-22 2 KIT in 1 CARTON (0597-0545-22) / 1 KIT in 1 KIT * 1 SYRI... Adalimumab-adbm Boehringer Ingelheim Pharmaceuticals, Inc. 2023-10-01
00597-0555-80 2 KIT in 1 CARTON (0597-0555-80) / 1 KIT in 1 KIT * 2 PACK... Adalimumab-adbm Boehringer Ingelheim Pharmaceuticals, Inc. 2023-10-01
00597-0565-20 2 KIT in 1 CARTON (0597-0565-20) / 1 KIT in 1 KIT * 1 SYRI... Adalimumab-adbm Boehringer Ingelheim Pharmaceuticals, Inc. 2024-04-30
00597-0575-50 2 KIT in 1 CARTON (0597-0575-50) / 1 KIT in 1 KIT * 1 SYRI... Adalimumab-adbm Boehringer Ingelheim Pharmaceuticals, Inc. 2024-04-30
00597-0585-89 2 KIT in 1 CARTON (0597-0585-89) / 1 KIT in 1 KIT * 1 SYRI... Adalimumab-adbm Boehringer Ingelheim Pharmaceuticals, Inc. 2023-10-01
00597-0595-20 2 KIT in 1 CARTON (0597-0595-20) / 1 KIT in 1 KIT * 1 SYRI... Adalimumab-adbm Boehringer Ingelheim Pharmaceuticals, Inc. 2023-10-01
Observed labelers: Boehringer Ingelheim Pharmaceuticals, Inc. (12) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.